Böttcher, R., Henderson, D. J. P., Dulla, K., van Strijp, D., Waanders, L. F., Tevz, G., . . . Hoffmann, R. (2015). Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression. Br J Cancer.
Citación estilo ChicagoBöttcher, R., et al. "Human Phosphodiesterase 4D7 (PDE4D7) Expression Is Increased in TMPRSS2-ERG-positive Primary Prostate Cancer and Independently Adds to a Reduced Risk of Post-surgical Disease Progression." Br J Cancer 2015.
Cita MLABöttcher, R., et al. "Human Phosphodiesterase 4D7 (PDE4D7) Expression Is Increased in TMPRSS2-ERG-positive Primary Prostate Cancer and Independently Adds to a Reduced Risk of Post-surgical Disease Progression." Br J Cancer 2015.